Get the Stockscreener App
51.97
0.00%
0.0338
Doximity Inc stock is traded at $51.97, with a volume of 583.83K.
It is up +0.00% in the last 24 hours and down -8.68% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$51.94
Open:
$51.46
24h Volume:
583.83K
Relative Volume:
0.23
Market Cap:
$7.11B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
51.97
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
+1.81%
1M Performance:
-8.68%
6M Performance:
-2.00%
1Y Performance:
+87.18%
1-Day Range:
$51.15
$52.00
1-Week Range:
$51.15
$52.80
52-Week Range:
$25.00
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
51.95 | 9.63B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
278.38 | 38.38B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
54.79 | 10.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.10 | 8.67B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
39.69 | 6.61B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity, Inc. (NASDAQ:DOCS) Receives $61.22 Average Target Price from Brokerages - MarketBeat
Doximity (DOCS) Poised to Benefit from Evolving Healthcare Engagement Trends | DOCS Stock News - GuruFocus
Wealthedge Investment Advisors LLC Makes New Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Mackenzie Financial Corp Invests $7.14 Million in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Upcoming Opportunities in Patient Communication Solutions - openPR.com
JPMorgan Chase & Co. Lowers Doximity (NASDAQ:DOCS) Price Target to $60.00 - MarketBeat
Nuveen Asset Management LLC Grows Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Position Reduced by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - MarketBeat
Voloridge Investment Management LLC Decreases Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (DOCS) Price Target Lowered by JP Morgan | DOCS Stock News - GuruFocus
Doximity (DOCS) Price Target Lowered by JPMorgan | DOCS Stock Ne - GuruFocus
Doximity (DOCS) Price Target Lowered by JPMorgan | DOCS Stock News - GuruFocus
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 379,566 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
The Strong Earnings Posted By Doximity (NYSE:DOCS) Are A Good Indication Of The Strength Of The Business - Yahoo
Doximity (NASDAQ:DOCS) PT Set at $50.00 by The Goldman Sachs Group - MarketBeat
Cache Advisors LLC Takes $753,000 Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Nomura Holdings Inc. Takes Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Man Group plc Decreases Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity’s SWOT analysis: digital health leader faces growth challenges - Investing.com
Strategic Global Advisors LLC Takes $1.51 Million Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Teza Capital Management LLC Purchases Shares of 38,090 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Jim Cramer on Doximity (DOCS): “I Cannot Get Behind That” - MSN
Jim Cramer Discussed These 9 Stocks Recently - Insider Monkey
Global Telemedicine Market to grow at a CAGR of 14.69% by 2030, - openPR.com
Jim Cramer Praises Rivian, Recommends Pan American SilverLucid Group (NASDAQ:LCID), Doximity (NYSE:DOCS) - Benzinga
Gotham Asset Management LLC Has $2.56 Million Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Lazard Asset Management LLC Reduces Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Point72 Hong Kong Ltd Has $704,000 Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation - GlobeNewswire
Doximity (DOCS) Sees Increased Call Option Activity | DOCS Stock News - GuruFocus
Doximity to Present at the William Blair 45th Annual Growth Stock Conference - Bluefield Daily Telegraph
Doximity (DOCS): Goldman Sachs Lowers Price Target Amidst Neutral Rating | DOCS Stock News - GuruFocus
Doximity (DOCS): Goldman Sachs Lowers Price Target Amidst Neutra - GuruFocus
Goldman cuts Doximity stock price target to $50, maintains neutral By Investing.com - Investing.com Nigeria
Telemedicine for Healthcare Providers: Market Insights & - openPR.com
Goldman cuts Doximity stock price target to $50, maintains neutral - Investing.com Australia
Doximity, Inc. (NASDAQ:DOCS) Holdings Lifted by Polar Capital Holdings Plc - MarketBeat
Doximity (NASDAQ:DOCS) Stock Price Down 3.8% Following Analyst Downgrade - Defense World
Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Call Transcript - MSN
Decoding Doximity Inc (DOCS): A Strategic SWOT Insight - GuruFocus
Doximity: A Closer Look At Its Investment Potential - Barchart.com
Doximity: A Closer Look at Its Investment Potential - The Globe and Mail
Doximity (DOCS) Price Target Cut by Goldman Sachs Analyst | DOCS Stock News - GuruFocus
Doximity, Inc. SEC 10-K Report - TradingView
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):